Omya Boosts Supply of Active Pharmaceutical Ingredients
Omya’s manufacturing plant in Kemalpaşa, Turkey has gained health authority approval to produce GMP-compliant pharmaceutical ingredients aligned with ICH Q7.
Manufacture of calcium carbonate as an active pharmaceutical ingredient
Omya, a global leader in the production of industrial minerals – mainly derived from calcium carbonate, dolomite and perlite – and a worldwide distributor of specialty chemicals, has announced that its facility in Kemalpaşa/Izmir, Turkey has achieved Turkish Health Authority accreditation to manufacture calcium carbonate as an active pharmaceutical ingredient in line with the most stringent quality requirements and industry-leading GMP-compliant manufacturing practices set out in ICH Q7.
Alongside Omya’s manufacturing sites in the USA and France, the Turkey-based facility is now the third fully certified plant supplying the pharma, nutraceutical, and food industries. The plant is also compliant with the international ISO standards of “Basic Quality” (ISO 9001:2015), ‘’Environment” (ISO 14001:2011) and “Work Safety”. (ISO 45001:2018).
The company’s mineral particles are processed in Turkey from high-purity marble stone in accordance with the strictest sustainability and quality standards and with a very low environmental footprint. In the plant, ultrapure and white calcium carbonate is processed to various morphologies, thereby offering a broad range of products with multiple functionalities and applications.
The Omyapure® mineral ingredients can be used in antacid products and osteoporosis treatments
The resulting mineral ingredients designated for the pharmaceutical industry under the brand name Omyapure® offer numerous benefits for finished products, facilitate production processes and increase nutritional profiles. As such, Omyapure® can be used in antacid products as well as osteoporosis treatments, for example.
To successfully operate the plant while preserving and protecting its delicate surroundings, Omya is highly considerate of the environment in all areas of its activity.
Stefan Lander, Vice President Consumer Goods, Group Sales & Marketing at Omya, explains:
“Having our third plant now certified for the production of pharmaceutical actives and expanding our offerings from Kemalpasa will help us serve our global customers with natural and highly functional minerals, while maintaining a focus on economic and ecological efficiency, which is fully aligned with Omya’s purpose of making life better through our passion for minerals and chemistry.”
About Omya Group
Omya is a leading global manufacturer of industrial minerals – mainly derived from calcium carbonate, dolomite and perlite – and a worldwide distributor of specialty ingredients. With a rich history dating back to its establishment in Switzerland in 1884, Omya has a global presence extending to more than 175 locations in over 50 countries with 9,000 employees. Omya provides sustainable added value products and services from responsibly sourced materials to meet the needs of current and future generations. In the Consumer Goods sector, Omya offers innovative solutions based on high-purity natural minerals and complementary ingredients that comply with the most stringent regulatory and quality standards.
For further information, please visit: https://pharma-nutra.omya.com/